Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BXJ
|
|||
| Former ID |
DIB006977
|
|||
| Drug Name |
PF-5177624
|
|||
| Synonyms |
PF-05177624; 3-phosphoinositide-dependent kinase-1 inhibitor (cancer), Pfizer
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Pfizer Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells. PLoS One. 2012;7(10):e48402. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.